With approaches like high intensity focused ultrasound, patients with prostate cancer may experience lower rates of urinary ...

TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.

Prostate cancer is the second leading cause of cancer death among American men. A recent study, conducted by researchers from ...

Opening up about their below-the-belt health is not a conversation every man wants to have with his doctor, let alone his ...

North America Cancer Therapy Market Size Set Expands at Significant CAGR of 8.15% During 2024-2030 to Reach USD 5.87 Billion by 2030 Request To Download Free Sample of This Strategic Report @ ...

The Global Robotic Radiotherapy Market, valued at approximately USD 1.1 billion in 2023, is anticipated to witness a robust growth trajectory with a compound annual growth rate (CAGR) of 11.9% over ...

A global survey of breast cancer patients reveals a gap in support services for managing the mental and physical side effects ...

A team at the University of Cordoba and IMIBIC tested the protective effect of a fermented black garlic extract against ...

Oct. 15 (UPI) --A global survey of breast cancer patients reveals a gap in support services for managing the mental and physical side effects experienced by those undergoing treatment.

Triplet therapy using darolutamide vs abiraterone plus prednisone may lead to less cardiotoxicity in patients with metastatic hormone-sensitive prostate cancer (mHSPC). Steven Canfield ...

Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The ...